Cargando…
miR-370 Sensitizes TMZ Response Dependent of MGMT Status in Primary Central Nervous System Lymphoma
Primary central nervous system lymphoma (PCNSL) is an aggressive and rare subtype of non-Hodgkin lymphoma, arising exclusively in the CNS with a poor prognosis. Previous evidence has proved that MGMT was a promising target involving in TMZ resistance of PCNSL. Our study described a new miR-370-media...
Autores principales: | Li, Xinwei, Xu, Xueying, Chen, Keng, Wu, Haijian, Wang, Yirong, Yang, Shuxu, Wang, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242252/ https://www.ncbi.nlm.nih.gov/pubmed/30712191 http://dx.doi.org/10.1007/s12253-019-00605-4 |
Ejemplares similares
-
Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression
por: Gao, Yong-tao, et al.
Publicado: (2016) -
Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma
por: Gonzalez-Aponte, Maria F., et al.
Publicado: (2023) -
Experimental study of selective MGMT peptides mimicking TMZ drug resistance in glioma
por: Wu, Yue, et al.
Publicado: (2022) -
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma
por: Chai, Ruichao, et al.
Publicado: (2021) -
The potential role of Ku80 in primary central nervous system lymphoma as a prognostic factor
por: Li, Xinwei, et al.
Publicado: (2013)